NCT06963502 2025-05-09A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid TumorsJiangsu Hansoh Pharmaceutical Co., Ltd.Phase 1 Not yet recruiting762 enrolled
NCT06394414 2025-02-24A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid TumorsMediLink Therapeutics (Suzhou) Co., Ltd.Phase 1 Recruiting162 enrolled
NCT02815592 2024-09-04Trial of BMS-986012 in Combination With Platinum and EtoposideBristol-Myers SquibbPhase 1 Completed12 enrolled